Immunotherapy Clinical Trial Aims for Mesothelioma Cure
Medical oncologist Dr. Bernardo Goulart at the Seattle Cancer Care Alliance (SCCA) believes his latest clinical trial might be the…
Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews
Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that clinical…